ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,533,012 | +27.1% | 226,419 | +41.7% | 0.00% | +50.0% |
Q3 2022 | $8,289,812 | +25.7% | 159,819 | +14.6% | 0.00% | 0.0% |
Q2 2022 | $6,594,449 | -33.6% | 139,506 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $9,930,037 | +6.8% | 139,506 | +12.2% | 0.00% | 0.0% |
Q4 2021 | $9,298,000 | +48.9% | 124,344 | +13.1% | 0.00% | +100.0% |
Q3 2021 | $6,245,000 | +29.1% | 109,936 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $4,838,000 | -23.9% | 109,936 | -14.7% | 0.00% | 0.0% |
Q1 2021 | $6,358,000 | -1.9% | 128,914 | -16.3% | 0.00% | -50.0% |
Q4 2020 | $6,483,000 | -11.3% | 154,002 | -3.6% | 0.00% | 0.0% |
Q3 2020 | $7,311,000 | -11.8% | 159,694 | -3.3% | 0.00% | 0.0% |
Q2 2020 | $8,289,000 | -23.7% | 165,085 | -21.8% | 0.00% | -50.0% |
Q1 2020 | $10,859,000 | -16.8% | 211,132 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $13,044,000 | +2.8% | 211,132 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $12,685,000 | -24.5% | 211,132 | +6.0% | 0.00% | -20.0% |
Q2 2019 | $16,804,000 | -6.6% | 199,146 | +5.8% | 0.01% | -16.7% |
Q1 2019 | $17,987,000 | +153.1% | 188,301 | +87.7% | 0.01% | +100.0% |
Q4 2018 | $7,106,000 | -4.7% | 100,326 | +15.0% | 0.00% | +50.0% |
Q3 2018 | $7,456,000 | – | 87,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |